Messer Starts Operation of New Green CO2 Plant in Czechia
German family-owned industrial gases producer Messer has started operations at a new plant for the production of green carbon dioxide (CO2) at its Vrdy site in the Czech Republic.
News
Lonza Capsules & Health Ingredients Expands Capsule Manufacturing Capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region.
Thyssenkrupp Nucera Partners with Chlorum Solutions for US Chlor-Alkali Plant
Chlorum Solutions USA, a subsidiary of Brasil-based Chlorum Solutions group, partners with Thyssenkrupp Nucera to develop its first US chlor-alkali plant in Casa Grande, Arizona. The facility addresses the need for decentralized chemical production, enhancing supply chain resilience.
Merck & Co. Licenses Obesity Drug from Hansoh Pharma
US Merck & Co., operating as MSD outside the US and Canada, and Chinese biopharmaceutical company Hansoh Pharma have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist. GLP-1 receptor agonists are primarily used for the treatment of type 2 diabetes and obesity.
Toray to Build Pilot Facility for All-Carbon CO2 Separation Membrane in Japan
Japan’s Toray Industries plans to install a pilot facility for its all-carbon carbon dioxide (CO2) separation membrane at its plant in Shiga, Japan.
AbbVie to Buy Nimble Therapeutics for $200 Million
US biopharma AbbVie has signed an agreement to acquire US biotechnology company Nimble Therapeutics, including its lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for the treatment of psoriasis and a pipeline of other novel oral peptide candidates with potential across several autoimmune diseases.
Lonza Outlines Restructuring Strategy and New Organizational Structure
At an investor update at the end of last week, Lonza has announced its "One Lonza" restructuring strategy, which aims to reorganize its CDMO business, simplify its operating model, enhance manufacturing and engineering, and expand its production footprint.
Clariant Starts New Additives Line in China
Clariant is expanding its Cangzhou production site to manufacture the multifunctional additive Nylostab S-EED.
Novo Nordisk to Build New Production Facility in Odense, Denmark
Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark.
Newron Licenses Schizophrenia Treatment to EA Pharma
Italian drugmaker Newron Pharmaceuticals and EA Pharma, a subsidiary of Japan’s Eisai, today have entered into a license agreement to develop, manufacture and commercialize Newron’s evenamide in Japan and other designated Asian territories.
Austria: A Hotspot for Life Sciences
An Attractive and Highly Sought-after Business Location
The life sciences sector, encompassing biotechnology, pharmaceuticals and medical technology, is developing rapidly in Austria.
Substantial Progresses in Sustainability Focus Areas
The Italian Olon Group, a leading international supplier of active pharmaceutical ingredients (APIs), presents the 2023 Corporate Sustainability Report and confirms the sustainability journey toward energy transition, investments in alternative energy sources, social and economic involvement and support for the communities in which it operates
Greensand CCS Project Partners Take Final Investment Decision
Ineos and its partners Harbour Energy and Nordsøfonden have taken the final investment decision (FID) into the first commercial phase ‘Greensand Future’ with storage operations in a depleted oil field in the Danish North Sea set to begin at the end of 2025/early 2026.
Samabriva Opens Biomanufacturing Facility in Belgium
French biotechnology company Samabriva has opened a new 1,400 m2 biomanufacturing facility in Liege, Belgium. The multi-million Euros investment is designed to provide industrial-scale production of high-value natural molecules used in the manufacture of pharmaceutical products, the company said.
Amgen Plans $1 Billion Manufacturing Expansion in North Carolina
In a move to expand its global biomanufacturing network, US biopharma Amgen is planning to invest $1 billion to build a second drug substance manufacturing facility at its US site in Holy Springs, North Carolina. This brings the company's total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment.
Navigating the Future of Chemical Distribution
In 2024, the chemical distribution industry is at a pivotal moment, navigating both challenges and new opportunities. As distributors grapple with a landscape shaped by shifting global trade routes, demand constraints, and digital disruption, their roles are evolving far beyond traditional bulk breaking.
Doppelganger Plastics: A More Desirable Alternative?
Plastics are highly effective but environmentally damaging. PET is a prime example, being cheap and recyclable yet oil-based. With plastics set to consume 20% of global oil and gas by 2050, sustainable alternatives are crucial. Enter PEF, a bioplastic that could revolutionize the industry. Can PEF be the solution we need?
CSDDD: The Formula for a Sustainable Chemical Industry?
The EU's Corporate Sustainability Due Diligence Directive (CSDDD) is reshaping the chemical industry's approach to environmental and social responsibility. A close look at the requirements reveals significant changes to supply chain oversight, risk management, and sustainability reporting. Chemical companies must implement new strategies to ensure compliance, drive innovation, and adapt to evolving regulations.
Transforming Distribution Strategies
Experts of Ataman Chemicals, Barentz, Biesterfeld, Brenntag, BÜFA Chemicals, CSC Jaeklechemie, Häffner, IMCD, Krahn Chemie, Möller Chemie, Nordmann, RN Chemicals, and Stockmeier share their opinions
Statement: Arthur Jaunich, CEO, Stockmeier Chemicals
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Dany Njeim, CEO, RN Chemicals
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Gerd Bergmann, Managing Director, Nordmann
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Pia Berghaus, Vice President, Möller Chemie
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Thomas Dassler, CEO, Häffner
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Rolf Kuropka, CEO, Krahn Chemie Group
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Lars Schneider, EMEA CEO, Barentz
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Robert Spaeth, Managing Partner, CSC Jaeklechemie
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges
Statement: Laurens Muijs van de Moer, Managing Director, BÜFA Chemicals
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Mehmet Tolga Tuncel, Managing Director, Ataman Chemicals
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Ewout van Jarwaarde, CEO, Brenntag Essentials
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Stephan Glander, CEO, Biesterfeld
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Lars Wallstein, Managing Director, IMCD Germany
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Statement: Michael Friede, CEO, Brenntag Specialties
CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Pioneering Sustainability in Pharma Excipients
Interview with Olli Kähkönen, Nordic Bioproducts Group
Giving Environmental Data an Exact Price Tag for Businesses
Interview with Franziska Walde and Lukas Fischer, Refinq
